| 摘要 |
The strain of Lactobacillus helveticus deposited as CNCM I-3431, and its variants and mutants, are new. Independent claims are included for the following: (1) strain (B) of L.helveticus that, when grown at 30-45, best 37, [deg]C on a milk-based medium of total protein content at least 2, especially 4, wt.% produces the tripeptides IleProPro (I) and/or ValProPro (II) at at least 65, especially 85, mg of (II) equivalent per kg of fermented product; (2) food product (C), especially fermented dairy product, that comprises at least one of (A) and (B); and (3) method for producing (C). ACTIVITY : Hypotensive. No details of tests for hypotensive activity are given. MECHANISM OF ACTION : Tripeptides (I) and (II) are known inhibitors of angiotensin-converting enzyme (ACE). |
